State | Closed |
Type | Subsidiary |
Parent Company | Lundbeck |
HQ | Bothell, WA, US |
Founded | 2004 |
Website | alderbio.com |
Cybersecurity rating | AMore |
Founding Date | 2004 |
Total Funding | $355 m |
Investors | Sevin Rosen Funds, TPG, Redmile Group, Delphi Ventures, Ventures West, WRF Capital, H.I.G. Capital, Novo Ventures |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 113.0k | ||||||||||||||||
Cost of goods sold | 113.0k | 683.0k | |||||||||||||||
Gross profit | |||||||||||||||||
General and administrative expense | 3.2m | 2.7m | 3.2m | 3.7m | 3.9m | 4.3m | 6.0m | 6.5m | 6.2m | 10.0m | 9.5m | 8.2m | 11.7m | 12.2m | 10.7m | 44.5m | 21.6m |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 12.9m | 70.3m | 57.6m | 209.9m | 408.0m | 234.0m | 178.0m | 230.0m | 170.6m | 79.7m | 127.8m | 87.3m | 202.0m | 115.8m | 94.4m | 126.1m | 88.4m |
Accounts Receivable | 91.0k | 57.0k | 81.0k | ||||||||||||||
Prepaid Expenses | 1.3m | 4.1m | 7.1m | 11.3m | 13.7m | 13.6m | 16.6m | 15.8m | 23.7m | 19.8m | 21.2m | 17.6m | 7.3m | 7.6m | 6.6m | 3.8m | 11.0m |
Inventories | 936.0k | 936.0k | 936.0k | 936.0k | 936.0k |
USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (5.4m) | (12.8m) | 15.9m | (14.7m) | (32.3m) | (59.3m) | (33.4m) | (72.2m) | (107.4m) | (100.3m) | (175.0m) | (234.5m) | (87.0m) | (155.4m) | (216.3m) | (117.9m) | (176.3m) |
Depreciation and Amortization | 188.0k | 355.0k | 527.0k | 195.0k | 385.0k | 571.0k | 235.0k | 505.0k | 1.0m | 747.0k | 1.5m | 2.2m | 801.0k | 1.6m | 2.1m | 533.0k | 1.1m |
Inventories | (936.0k) | (936.0k) | |||||||||||||||
Accounts Payable | (518.0k) | 448.0k | (539.0k) | 305.0k | 443.0k | 5.8m | 4.9m | 2.9m | 968.0k | 10.3m | 9.8m | 12.5m | 5.3m | 8.0m | 8.2m | 6.4m | (1.3m) |
USD | Q1, 2014 |
---|---|
Financial Leverage | -0.1 x |
Alder BioPharmaceuticals has 195 Twitter Followers. The number of followers has increased 1.4% month over month and increased 16.1% quarter over quarter
When was Alder BioPharmaceuticals founded?
Alder BioPharmaceuticals was founded in 2004.
Who are Alder BioPharmaceuticals key executives?
Alder BioPharmaceuticals's key executives are John Latham, Larry Benedict and Mark Litton.
How many employees does Alder BioPharmaceuticals have?
Alder BioPharmaceuticals has 202 employees.
Who are Alder BioPharmaceuticals competitors?
Competitors of Alder BioPharmaceuticals include Bencard Allergie, Chiesi Pharmaceutical and KLAB.
Where is Alder BioPharmaceuticals headquarters?
Alder BioPharmaceuticals headquarters is located at 11804 North Creek Pkwy, Bothell.
Where are Alder BioPharmaceuticals offices?
Alder BioPharmaceuticals has an office in Bothell.
How many offices does Alder BioPharmaceuticals have?
Alder BioPharmaceuticals has 1 office.
Receive alerts for 300+ data fields across thousands of companies